308 related articles for article (PubMed ID: 12982647)
1. Folic acid antagonists in therapy of leukemia and tumors; problem of resistance and relations with the citrovorum factor.
PAOLINO W
Minerva Med; 1952 Jun; 43(48):1296-1300. PubMed ID: 12982647
[No Abstract] [Full Text] [Related]
2. Citrovorum factor; nutritional aspects, associations with leukemia and anemia.
BAUMANN CA
J Am Diet Assoc; 1953 Jun; 29(6):548-54. PubMed ID: 13061228
[No Abstract] [Full Text] [Related]
3. Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy.
DUFF JK; SULLIVAN RD; MILLER E; ULM AH; CLARKSON BD; CLIFFORD P
Cancer; 1961; 14():744-52. PubMed ID: 13724783
[No Abstract] [Full Text] [Related]
4. Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer.
SULLIVAN RD; MILLER E; SIKES MP
Cancer; 1959; 12():1248-62. PubMed ID: 13835650
[No Abstract] [Full Text] [Related]
5. [Associated citrovorum factor-aminopterin treatment in acute leukemia].
CONSOLI G
Sang; 1955; 26(4):426-34. PubMed ID: 13246578
[No Abstract] [Full Text] [Related]
6. Some theoretical and practical aspects of the use of folic acid antagonists in human neoplasia.
GREENSPAN EM
J Mt Sinai Hosp N Y; 1952; 19(4):583-95. PubMed ID: 13000382
[No Abstract] [Full Text] [Related]
7. Continuous arterial infusion of methotrexate with intermittent, intramuscular citrovorum factor therapy in head and neck cancer.
SULLIVAN RD
Trans Pac Coast Otoophthalmol Soc Annu Meet; 1961; 42():29-42. PubMed ID: 13918329
[No Abstract] [Full Text] [Related]
8. The treatment of head and neck cancer with the continuous arterial infusion of methotrexate and the intermittent intramuscular administration of citrovorum factor.
SULLIVAN RD; DALY JF
Trans Am Laryngol Assoc; 1961; 82():54-72. PubMed ID: 13918323
[No Abstract] [Full Text] [Related]
9. Role of folic acid and citrovorum factor in metabolic processes and their relation to cancer.
BROQUIST HP
Tex Rep Biol Med; 1952; 10(4):953-60. PubMed ID: 13028998
[No Abstract] [Full Text] [Related]
10. Continuous intraarterial methotrexate with simultaneous, intermittent, intramuscular citrovorum factor herapy in carcinoma of the cervix.
SULLIVAN RD; WOOD AM; CLIFFORD P; DUFF JK; TRUSSEL R; NARY DK; BURCHENAL JH
Cancer Chemother Rep; 1960 Jul; 8():1-6. PubMed ID: 13835652
[No Abstract] [Full Text] [Related]
11. The formation of citrovorum factor in the developing chick egg and the effect of injecting folic acid antagonists.
SWENDSEID ME; JACKSON R; BENSON EM
Arch Biochem Biophys; 1958 Nov; 78(1):221-6. PubMed ID: 13595920
[No Abstract] [Full Text] [Related]
12. [Aminopterin in the treatment of malignant leukemia and its antidote--folic acid].
MALLARME J
Sang; 1952; 23(7):605-6. PubMed ID: 13004914
[No Abstract] [Full Text] [Related]
13. The role of the Leuconostoc citrovorum factor (LCF) in cell division and the mode of action of folic-acid antagonists on normal and leukaemic cells.
JACOBSON W
J Pathol Bacteriol; 1952 Jan; 64(1):245-7. PubMed ID: 14908808
[No Abstract] [Full Text] [Related]
14. Treatment of acute leukemia with anti-folic acid compounds (aninopterin and aminoanfol).
SAWITSKY A; RITZ ND; JACOBSON J; MEYER LM; SCHWARTZ SO; KRIM M; BOCK G; BRAHIN CM
Cancer; 1952 Mar; 5(2):344-53. PubMed ID: 14905421
[No Abstract] [Full Text] [Related]
15. Further observations on the effect of aminopterin, a-methopterin and citrovorum factor on the growth of transplantable avian lymphoid tumours.
CHUBB LG; LAURSEN AL
Br J Pharmacol Chemother; 1954 Dec; 9(4):419-22. PubMed ID: 13219264
[No Abstract] [Full Text] [Related]
16. Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase.
STOVNER J; ENGSETH A; BRENNHOVD I
Cancer Chemother Rep; 1962 Aug; 21():147-8. PubMed ID: 13917570
[No Abstract] [Full Text] [Related]
17. An unusual case of acute plasma-cell leukemia treated with a folic acid antagonist and urethane.
MEYER LM; RUTZKY J
Cancer; 1951 Sep; 4(5):1043-51. PubMed ID: 14879373
[No Abstract] [Full Text] [Related]
18. Increase of urinary citrovorum factor activity in patients receiving methotrexate (amethopterin).
LI MC; NIXON WE; FREEMAN MV
Proc Soc Exp Biol Med; 1958 Jan; 97(1):29-32. PubMed ID: 13518171
[No Abstract] [Full Text] [Related]
19. The folic acid antagonists in the treatment of leukemia.
CHIARENZA JJ
BMQ; 1956 Sep; 7(3):76-83. PubMed ID: 13363766
[No Abstract] [Full Text] [Related]
20. Resistance to corticotropin, cortisone, and folic acid antagonists in leukemia.
PILLERS EM; BURCHENAL JH; ELIEL LP; PEARSON OH
J Am Med Assoc; 1952 Mar; 148(12):987-94. PubMed ID: 14897698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
